GlassScriptPhysician profile
Joyce A Struna
NPI 1003068263
$2,569.56
in general payments reported to CMS, 2019-2025
23 companies · $517 in 2025
The $517 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $802 · 2022: $1,026 · 2023: $146 · 2024: $77.93 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $741.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $651.47 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $461.53 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $197.35 | 2021-2025 | Xifaxan |
| Janssen Pharmaceuticals, INC | $178.74 | 2021-2022 | |
| Lilly USA, LLC | $160.55 | 2021-2025 | Mounjaro, Zepbound |
| Amgen INC. | $152.61 | 2021-2025 | Prolia, Evenity |
| Exact Sciences Corporation | $144.92 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $90.56 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.45 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $86.64 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $53.14 | 2022 | |
| Pfizer INC. | $49.86 | 2021-2025 | |
| Glaxosmithkline, LLC. | $45.75 | 2021-2022 | |
| Corcept Therapeutics | $31.83 | 2025 | Korlym |
| Organon LLC | $25.64 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $23.83 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbott Laboratories | $23.55 | 2022 | |
| Ironwood Pharmaceuticals, INC | $20.86 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $18.48 | 2022 | |
| Almatica Pharma LLC | $16.23 | 2022 | |
| Idorsia Pharmaceuticals US INC | $16.13 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.53 | 2022 | |
| Phathom Pharmaceuticals, INC. | $13.91 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Struna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.